Remove 2025 Remove Debt Financing Remove Marketability
article thumbnail

OHA is Administrative Agent and Lead Left Arranger of Private Debt Financing Supporting Montagu's Acquisition of Tyber Medical

Benzinga

New York, New York, June 18, 2025 (GLOBE NEWSWIRE) -- Oak Hill Advisors ("OHA") served as Administrative Agent and Lead Left Arranger for the private senior debt financing supporting the acquisition of Tyber Medical, LLC ("Tyber Medical") by Montagu Private Equity ("Montagu").

article thumbnail

Sustainable Finance Awards 2025: Africa

Global Finance

Various organizations throughout the African countries have made environmental, social, and governance (ESG) concerns a high priorityfor example, advancing sustainability disclosure practices across capital markets. The group structured the debt financing for Scatecs Mogobe battery energy storage system project.

Finance 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Sustainable Finance Awards 2025: Asia-Pacific

Global Finance

This company acts as a centralized financial enterprise, providing financial market infrastructure services to banks across China. Also in Australia, SocGen acted as mandated lead arranger for $400 million Australian dollars (about $255 million) in debt financing for construction of the third phase of the Melbourne Renewable Energy Hub.

Finance 52
article thumbnail

Fed Rate Cut Fuels Acquisition Boom: Why Now Is the Time to Act

Scott Mashuda

This pivot from an inflation-focused stance to one prioritizing employment has opened up a world of opportunities, particularly in the lower middle market. This sentiment, coupled with the rate cuts, sets the stage for a potentially vibrant acquisition market.

Finance 83
article thumbnail

Windtree Announces Transformational Agreement to Acquire Revenue Generating Environmental Services Business

Benzinga

June 10, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. As consideration for the transaction, Windtree will issue preferred shares and has secured debt financing to fund the transaction and working capital for the business.

article thumbnail

Sharps Technology Signs Asset Purchase Agreement to Acquire InjectEZ Specialty Copolymer Syringe Manufacturing Facility and a 10-Year Purchase Agreement for Over $400 Million from Nephron Pharmaceuticals

Benzinga

Product delivery is scheduled for the first quarter of 2024 with revenue totaling approximately $30 Million for the first twelve months of production and subsequent revenue of over $45 Million per year beginning in 2025, and continuing through 2033. 26, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc.

article thumbnail

Rafael Holdings and Cyclo Therapeutics Enter into a Definitive Merger Agreement

Benzinga

Cyclo Therapeutics' TransportNPC™ Phase 3 clinical trial for Trappsol ® Cyclo™ for the treatment of Niemann-Pick Disease Type C1, a rare and fatal genetic disease, is fully enrolled and results from the 48-week interim analysis are expected in the middle of 2025 NEWARK, N.J. and GAINESVILLE, Fla.,